SwePub
Sök i SwePub databas

  Utökad sökning

Booleska operatorer måste skrivas med VERSALER

AND är defaultoperator och kan utelämnas

Träfflista för sökning "AMNE:(MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology) srt2:(1995-1999)"

Sökning: AMNE:(MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology) > (1995-1999)

  • Resultat 361-366 av 366
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
361.
  • Zeidman, Ruth, et al. (författare)
  • Novel and classical protein kinase C isoforms have different functions in proliferation, survival and differentiation of neuroblastoma cells
  • 1999
  • Ingår i: International Journal of Cancer. - 0020-7136. ; 81:3, s. 494-501
  • Tidskriftsartikel (refereegranskat)abstract
    • To elucidate the possibility of utilizing protein kinase C (PKC) isoforms as target genes in neuroblastoma therapy, 5 neuroblastoma cell lines and neuroblastoma tumor specimens were examined for PKC isoform expression pattern and the cell lines were analyzed for sensitivity to PKC inhibition. All cell lines [IMR-32, LAN-2, LAN-5, SH-SY5Y and SK-N-BE(2)] expressed alpha, betaII, delta and epsilon isoforms of PKC, while no PKCeta or theta protein was detected in any cell line. PKCgamma was found only in LAN-2 cells. PKCalpha, betaII and delta were detected in 5 neuroblastoma tumors and PKCepsilon in 4 out of 5 tumors. Exposure to the PKC inhibitors GF109203X, Go 6976 or Go 6983 caused a decrease whereas activation of PKC with 12-O-tetradecanoyl phorbol 13-acetate caused an increase in the number of neuroblastoma cells. The effect of Go 6976 was due to both inhibited proliferation and to increased apoptosis. While GF109203X suppressed neurite outgrowth induced by a growth factor combination, Go 6976 potentiated neurite outgrowth. Our data suggest a role for classical PKC isoforms in neuroblastoma growth and survival and for novel isoforms in neurite outgrowth.
  •  
362.
  • Zätterstrom, Ulf K, et al. (författare)
  • Radiation effects on S-phase duration, labelling index, potential doubling time and DNA distribution in head and neck cancer xenografts
  • 1995
  • Ingår i: Acta Oncologica. - : Informa UK Limited. - 1651-226X .- 0284-186X. ; 34:2, s. 205-211
  • Tidskriftsartikel (refereegranskat)abstract
    • The effect of irradiation on S-phase duration (Ts), labelling index (LI), potential doubling time (Tpot), and cell cycle phase distributions was determined by DNA flow cytometry in xenografted human squamous cell carcinoma of the head and neck (SCCHN). Tumours were treated with a single dose of 3 Gy, and excised at intervals over a 90-h period. Six hours before each excision the tumours were labelled in vivo with bromodeoxyuridine (BrdUrd). Although the growth rate of irradiated tumours was comparable with that of untreated controls, analysis of BrdUrd uptake revealed a transient reduction of LI and a prolongation of Ts in irradiated tumours. Maximum mean Tpot was 931 days in irradiated tumours as compared to 13 days in untreated controls. The variations in Ts, LI and Tpot all occurred within the first hours after irradiation; during the remainder of the observation time, the values of the variables did not differ from those of untreated controls. In irradiated tumours the distribution of cells according to DNA content changed significantly on three occasions during the observation period: 1) Parallel to the initial lowering of LI and prolongation of Ts there was a transient increase in the proportion of cells in G0/G1 and a decrease in the proportion of cells in S and G2; 2) At 18 h, the most pronounced cell cycle phase redistribution occurred when the G0/G1 fraction decreased and the S and G2 phase fractions increased; 3) At 66 h (i.e., approximately one cell cycle later), the pattern was the same as that after 18 h. The findings suggest that the transient prolongation of DNA replication seen in SCCHN cells immediately after a single radiation dose is a symptom of DNA damage inflicted during late G1 or early S-phase, and that this disturbance in DNA synthesis is associated with the subsequent accumulation of cells in G2 phase.
  •  
363.
  • Åkerman, Måns (författare)
  • Fine-needle aspiration cytology of soft tissue sarcoma: benefits and limitations.
  • 1998
  • Ingår i: Sarcoma. - : Hindawi Limited. - 1357-714X .- 1369-1643. ; 2:3-4, s. 155-161
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose. Examine the benefits and limitations of fine-needle aspiration cytology (FNA) used as the definitive diagnostic method before treatment.Method. Review of the 25 year experience at a multidisciplinary musculo-skeletal centre where FNA is the primary diagnostic approach to soft tissue sarcoma in the extremities and trunk wall and the experience of various experts in the field.Results. FNA has several benefits compared with coarse needle or open surgical biopsy. The most important are rapid preliminary diagnosis, no need for hospitalization and anaesthesia, negligible complications and fear for tumour cell spread. With the collected experience gained during the years a reliable diagnosis of sarcoma is the rule in general and specific-type diagnoses are possible in many histotypes, especially when the cytologic examination is supplemented with ancillary diagnostics. The most important limitations are inability to hit small deep-seated sarcoma and some diagnostic pitfalls such as the correct diagnosis of spindle cell neoplasms, variants of benign lipomatous tumours and 'new soft tissue tumour entities'.Discussion. Optimal use of FNA calls for certain requirements such as centralization, experience in soft tissue tumour cytology-histopathology, the FNA technique and close co-operation between the orthopaedic surgeon and cytopathologist.
  •  
364.
  • Åkervall, Jan, et al. (författare)
  • Complex karyotypes in flow cytometrically DNA-diploid squamous cell carcinomas of the head and neck
  • 1998
  • Ingår i: British Journal of Cancer. - 1532-1827. ; 77:7, s. 1082-1088
  • Tidskriftsartikel (refereegranskat)abstract
    • In squamous cell carcinoma of the head and neck (SCCHN), DNA ploidy as determined by flow cytometry (FCM) has been found to yield prognostic information but only for tumours at oral sites. Cytogenetic findings have indicated complex karyotype to be a correlate of poor clinical outcome. In the present study, 73 SCCHN were investigated with the two techniques. Aneuploid cell populations were identified in 49 (67%) cases by FCM but in only 21 (29%) cases by cytogenetic analysis. The chromosome index (CI), calculated as the mean chromosome number divided by 46, was compared with the respective DNA index (DI) obtained by FCM in 15 tumours, non-diploid according to both techniques, DI being systematically 12% higher than CI in this subgroup. Eight (33%) of the 24 tumours diploid according to FCM had complex karyotypes, three of the tumours being cytogenetically hypodiploid, three diploid and two non-diploid. The findings in the present study may partly explain the low prognostic value of ploidy status as assessed by FCM that has been observed in SCCHN. In addition, we conclude that FCM yields information of the genetic changes that is too unspecific, and that cytogenetic analysis shows a high rate of unsuccessful investigations, thus diminishing the value of the two methods as prognostic factors in SCCHN.
  •  
365.
  • Åström, Lennart, et al. (författare)
  • S-phase fraction related to prognosis in localised prostate cancer. No specific significance of chromosome 7 gain or deletion of 7q31.1.
  • 1998
  • Ingår i: International journal of cancer. Journal international du cancer. - 0020-7136. ; 79:6, s. 553-9
  • Tidskriftsartikel (refereegranskat)abstract
    • A flow-cytometric (FCM) and fluorescence in situ hybridization (FISH) study was performed in 153 patients with clinically localised prostate cancer (PC) to evaluate retrospectively the prognostic significance of DNA ploidy, S-phase fraction (SPF) and chromosome 7 copy number. Deletions in 7q31.1 were analysed in a subset of 26 tumours. The mean follow-up time was 6 years (range 4-16 years). Twelve cases of benign prostatic hyperplasia (BPH) were studied as a control. Chromosome 7 enumeration and deletion studies were conducted using the alpha-satellite D7Z1 probe and a cosmid probe specific for the marker D7S522 on 7q31.1. Higher SPF was associated with shorter overall survival and shorter time to local progression and metastasis. Near diploid (DNA index 1.05-1.20) cases had a lower frequency of metastases and lower Gleason scores than aneuploid cases. Increased absolute chromosome 7 copy number (centromere count) was associated with higher Gleason score, higher SPF and shorter local progression-free and prostate cancer survival. Absolute chromosome 7 copy number was concordant with FCM DNA ploidy in the majority (75%) of cases. Relative gain or loss of chromosome 7 (centromere counts compared to ploidy) was infrequent, and no correlation was found with clinical parameters. Deletions in 7q31.1 were infrequent. Our results indicate that in localised PC (i) SPF is a prognostic factor, (ii) absolute chromosome 7 copy number is concordant with the ploidy status of the tumour (relative gain or loss of chromosome 7 is infrequent and has no independent prognostic value) and (iii) the frequency of deletions in 7q31.1 is low and not correlated with clinical outcome.
  •  
366.
  • Bjordal, K, et al. (författare)
  • 1999
  • Ingår i: Journal of Clinical Oncology. - 1527-7755. ; 17:3, s. 1008-1019
  • Tidskriftsartikel (refereegranskat)abstract
    • PURPOSE: The aim of this study was to define the scales and test the validity, reliability, and sensitivity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-H&N35, a questionnaire designed to assess the quality of life of head and neck (H&N) cancer patients in conjunction with the general cancer-specific EORTC QLQ-C30. PATIENTS AND METHODS: Questionnaires were given to 500 H&N cancer patients from Norway, Sweden, and the Netherlands as part of two prospective studies. The patients completed the questionnaires before, during (Norway and Sweden only), and after treatment, yielding a total of 2070 completed questionnaires. RESULTS: The compliance rate was high, and the questionnaires were well accepted by the patients. Seven scales were constructed (pain, swallowing, senses, speech, social eating, social contact, sexuality). Scales and single items were sensitive to differences between patient subgroups with relation to site, stage, or performance status. Most scales and single items were sensitive to changes, with differences of various magnitudes according to the site in question. The internal consistency, as assessed by Cronbach's alpha coefficient, varied according to assessment point and within subsamples of patients. A low overall alpha value was found for the speech and the senses scales, but values were higher in assessments of patients with laryngeal cancer and in patients with nose, sinus, and salivary gland tumors. Scales and single items in the QLQ-H&N35 seem to be more sensitive to differences between groups and changes over time than do the scales and single items in the core questionnaire. CONCLUSION: The QLQ-H&N35, in conjunction with the QLQ-C30, provides a valuable tool for the assessment of health-related quality of life in clinical studies of H&N cancer patients before, during, and after treatment with radiotherapy, surgery, or chemotherapy.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 361-366 av 366
Typ av publikation
tidskriftsartikel (313)
doktorsavhandling (33)
forskningsöversikt (6)
bokkapitel (6)
konferensbidrag (5)
rapport (2)
visa fler...
bok (1)
visa färre...
Typ av innehåll
refereegranskat (319)
övrigt vetenskapligt/konstnärligt (46)
populärvet., debatt m.m. (1)
Författare/redaktör
Olsson, Håkan (44)
Ahlman, Håkan, 1947 (34)
Wängberg, Bo, 1953 (34)
Nilsson, Ola, 1957 (30)
Borg, Åke (24)
Baldetorp, Bo (21)
visa fler...
Forssell-Aronsson, E ... (17)
Fernö, Mårten (15)
Naredi, Peter, 1955 (14)
Tisell, Lars-Eric, 1 ... (14)
Lindblad, Per, 1953- (14)
Fjälling, M (13)
Kölby, Lars, 1963 (13)
Hultborn, Ragnar, 19 ... (11)
Adami, H-O (11)
Nyman, Jan, 1956 (10)
Killander, Dick (10)
Dasu, Alexandru (10)
Lilja, Hans (8)
Bendahl, Pär Ola (8)
Svanberg, Katarina (8)
Strand, Sven-Erik (8)
Ingvar, C (8)
Wennerberg, Johan (7)
Larsson, Christer (7)
Jernström, Helena (7)
Hafström, Lars-Olof, ... (7)
Olsson, H. (6)
Andersson-Engels, St ... (6)
Svanberg, Sune (6)
Wolk, A (6)
Bratt, O (6)
Westerdahl, J (6)
Tennvall, Jan (6)
Johannsson, O (6)
Björk-Eriksson, Thom ... (5)
Alm, Per (5)
Eriksson, Mikael (5)
Mertens, F (5)
Kjellén, Elisabeth (5)
Wang, I (5)
Lundgren, R (5)
Niwa, S (5)
Los, Marek Jan (5)
Wiebe, Thomas (5)
Saeter, G (5)
Alvegård, Thor (5)
Åkerman, Måns (5)
Karlsson, Mats G, 19 ... (5)
Loman, Niklas (5)
visa färre...
Lärosäte
Lunds universitet (191)
Göteborgs universitet (88)
Uppsala universitet (32)
Karolinska Institutet (21)
Örebro universitet (20)
Umeå universitet (17)
visa fler...
Linköpings universitet (16)
Chalmers tekniska högskola (7)
Högskolan i Halmstad (3)
Jönköping University (1)
Södertörns högskola (1)
visa färre...
Språk
Engelska (355)
Svenska (11)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (366)
Naturvetenskap (10)
Teknik (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy